Copyright
©The Author(s) 2003.
World J Gastroenterol. Aug 15, 2003; 9(8): 1848-1852
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1848
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1848
Table 1 Clinicopathological data of hyperglycemic and non-hyperglycemic patients with HCC
Variables | With hyperglycemia (n = 28) | Wthout hyperglycemia (n = 197) |
Age (year) | 55 ± 1.99 | 51.91 ± 1.08 |
HBsAg(+/-) | 15/13 | 110/87 |
Cirrhosis (+/-) | 20/8 | 133/64 |
Gender (male/female) | 23/5 | 157/40 |
Laboratory data | ||
ALT (U/L) | 48.91 ± 10.41 | 39.82 ± 11.21 |
PT (s) | 12.24 ± 0.20 | 12.67 ± 0.23 |
Albumin (g/L) | 39.63 ± 6.35 | 35.81 ± 7.86 |
Total bilirubin (μmmol/L) | 12.32 ± 7.15 | 13.54 ± 8.97 |
Platelet count ( × 109/L) | 158.41 ± 18.14 | 155.75 ± 7.37 |
TNM stage (I/II/III/IVa/IVb)a | 0/3/12/5/8 | 0/32/76/48/41 |
Child-Pugh grades (A/B/C) | 22/5/1 | 165/30/2 |
Sizes of the largest tumor (cm) | 3.80 ± 6.30 | 3.50 ± 6.75 |
Initial treatment (TACE/radiotherapy/ TACE+radiotherapy/ PEI/biotherapy) | 18/3/5/3/15 | 128/17/15/11/147 |
- Citation: Li XP, Chen Z, Meng ZQ, Huang WX, Liu LM. Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas. World J Gastroenterol 2003; 9(8): 1848-1852
- URL: https://www.wjgnet.com/1007-9327/full/v9/i8/1848.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i8.1848